Della Gravara, L.; Battiloro, C.; Letizia, A.; Cantile, R.; D'Agnano, V.; Sica, G.; Rocco, D.
Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients. J. Mol. Pathol. 2021, 2, 197-206.
https://doi.org/10.3390/jmp2020017
AMA Style
Della Gravara L, Battiloro C, Letizia A, Cantile R, D'Agnano V, Sica G, Rocco D.
Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients. Journal of Molecular Pathology. 2021; 2(2):197-206.
https://doi.org/10.3390/jmp2020017
Chicago/Turabian Style
Della Gravara, Luigi, Ciro Battiloro, Antonietta Letizia, Rosa Cantile, Vito D'Agnano, Giacomo Sica, and Danilo Rocco.
2021. "Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients" Journal of Molecular Pathology 2, no. 2: 197-206.
https://doi.org/10.3390/jmp2020017
APA Style
Della Gravara, L., Battiloro, C., Letizia, A., Cantile, R., D'Agnano, V., Sica, G., & Rocco, D.
(2021). Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients. Journal of Molecular Pathology, 2(2), 197-206.
https://doi.org/10.3390/jmp2020017